Brief, factual summary of the article in Slovak: The article deals with the regulation of the drug mifepristone by the Food and Drug Administration (FDA) in the USA from 2011 to 2023. Mifepristone is a drug used to terminate pregnancy. The article describes the evolution of the regulation of this drug by the FDA during the given period. It states that the FDA changed the rules for prescribing and distributing mifepristone in 2023. The article also includes a discussion of the political, scientific and regulatory aspects of this topic.